Credit Agricole’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$560K Hold
89,200
﹤0.01% 1174
2025
Q4
$1.09M Buy
+89,200
New +$1.46M ﹤0.01% 1024
2025
Q1
$772K Hold
89,200
﹤0.01% 967
2024
Q4
$434K Hold
89,200
﹤0.01% 1068
2024
Q3
$689K Hold
89,200
﹤0.01% 888
2024
Q2
$892K Buy
+89,200
New +$980K ﹤0.01% 750

Other funds holding OPRX

Credit Agricole's OPRX Position: Q1 2026 in Review

Credit Agricole held its OptimizeRx (OPRX) position steady in Q1 2026 at 89,200 shares worth $560K. The position accounts for ﹤0.01% of the portfolio, ranked #1174.

Credit Agricole first reported a position in OPRX in Q2 2024 and has held it in 6 quarters since. The position peaked at $1.09M in Q4 2025. 128 funds tracked by Wall St. Rank hold OPRX as of Q1 2026.

  • Credit Agricole held 89,200 shares of OptimizeRx worth $560K as of Q1 2026.
  • Credit Agricole left its OptimizeRx share count unchanged in Q1 2026.
  • OptimizeRx made up ﹤0.01% of Credit Agricole's portfolio in Q1 2026, its #1174 holding.
  • Credit Agricole first reported a position in OptimizeRx in Q2 2024 and has held it in 6 quarters since.
  • Credit Agricole's OptimizeRx position peaked at $1.09M in Q4 2025.
  • 128 funds tracked by Wall St. Rank held OptimizeRx as of Q1 2026.

Based on Credit Agricole's 13F filing for Q1 2026, filed 15 May 2026.